METRO I.V. Drug Patent Profile
✉ Email this page to a colleague
When do Metro I.v. patents expire, and when can generic versions of Metro I.v. launch?
Metro I.v. is a drug marketed by B Braun and is included in two NDAs.
The generic ingredient in METRO I.V. is metronidazole. There are eighteen drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metro I.v.
A generic version of METRO I.V. was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for METRO I.V.
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 172 |
Patent Applications: | 4,002 |
Formulation / Manufacturing: | see details |
DailyMed Link: | METRO I.V. at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for METRO I.V.
US Patents and Regulatory Information for METRO I.V.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B Braun | METRO I.V. | metronidazole | INJECTABLE;INJECTION | 018674-001 | Aug 31, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
B Braun | METRO I.V. IN PLASTIC CONTAINER | metronidazole | INJECTABLE;INJECTION | 018900-001 | Sep 29, 1983 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |